RSS-Feed abonnieren
PDF herunterladen
DOI: 10.1055/s-0043-1770068
Prevalence and Impact of HMOX1 Polymorphism (rs2071746: A > T) in Indian Sickle Cell Disease Patients
Funding Authors would like to acknowledge the financial support given by Indian Council of Medical Research (ICMR)-56/1/2019-HAE/BMS-), New Delhi, India, for the present study.
Abstract
Introduction Fetal hemoglobin (HbF) levels play significant role in lowering down the morbidity and mortality in sickle cell disease (SCD) patients. Coinheritance of heme oxygenase-1 (HMOX1) rs2071746:A > T polymorphism may contribute to variable HbF levels in Indian SCD patients.
Objective This study was aimed to evaluate the role of HMOX1 polymorphism and its impact on HbF level in Indian SCD patients.
Materials and Methods One-hundred twenty confirmed cases of SCD and 50 healthy controls were recruited. Their mean age was 11.5 ± 8.6 years (range: 3–23 years). Quantification of Hb, HbA2, HbF, and HbS was done by capillary zone electrophoresis. Allele-specific polymerase chain reaction was used to genotype HMOX1 (rs2071746:A > T) gene polymorphism.
Results Out of the 120 cases of SCD, 65 were hemoglobin sickle-shaped (HbSS) and 55 were sickle-beta thalassemia (Sβ). Out of 65 HbSS patients, 29 (44.6%) were heterozygous (AT), 20 (30.76%) were homozygous (TT), and 16 (24.61%) were found wild-type (AA) genotype. Out of 55 Sβ, 22 (40%) were heterozygous, 18 (32%) were homozygous and 15 (28%) were wild-type. Patients carrying HMOX1 (rs2071746:A > T), AT, and TT genotypes had less anemia, painful crisis, splenomegaly, hepatomegaly, jaundice, and blood transfusion. HbF level was found higher in TT genotype (in HbSS the HbF levels was 25.1 ± 4.4; in sickle-beta thalassemia the HbF levels was 36.1 ± 4.7) than wild-type(AA) and was statistically significant (p-value <0.001).
Conclusion The TT genotype of the rs2071746:A > T polymorphism was associated with increased levels of Hb F (p < 0.001). It can serve as a HbF modifier in Indian sickle cell diseases patients.
Authors' Contributions
H.R.P. designed the study, performed experimental studies, and drafted the manuscript. K.S. compiled the data and contributed to writing. R.R. and J.D. performed analysis and helped in drafting the manuscript. S.T. reviewed the manuscript and helped in shaping the manuscript. T.S., R.S., and M.M. provided valuable suggestions and clinical outputs. All authors read and approved the final the manuscript.
Statement of Informed Consent
All persons gave their informed consent prior to their inclusion in the study.
Publikationsverlauf
Eingereicht: 27. Juni 2022
Angenommen: 17. April 2023
Artikel online veröffentlicht:
19. Juni 2023
© 2023. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Frempong KO, Steinberg MH. Clinical aspects of sickle cell anaemia in adults and children. In: Steinberg MH, Forget BG, Higgs DR, Nagel RL, eds. Disorders of Hemoglobin: Genetics, Pathophysiology, and Clinical Management. 1st ed. Cambridge, England: Cambridge University Press; 2001: 611-670
- 2 Bunn HF. Pathogenesis and treatment of sickle cell disease. N Engl J Med 1997; 337 (11) 762-769
- 3 Kulozik AE, Wainscoat JS, Serjeant GR. et al. Geographical survey of β S-globin gene haplotypes: evidence for an independent Asian origin of the sickle-cell mutation. Am J Hum Genet 1986; 39 (02) 239-244
- 4 Platt OS, Brambilla DJ, Rosse WF. et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330 (23) 1639-1644
- 5 Noguchi C, Schechter AN, Rodgers GP. Sickle cell disease pathophysiology. In: Higgs DR, Weatherall DJ, eds. Bailliere's Clinical Haematology: The Haemoglobinopathies. Vol. 6. London: Bailliere Tindall; 1993: 57-91
- 6 Thein SL. Beta thalassaemia. In: Rodgers GP, ed. Bailliere's Clinical Haematology, Sickle Cell Disease and Thalassaemia, Vol. 11:1. London: Bailliere Tindall; 1998: 91-126
- 7 Garner C, Tatu T, Reittie JE. et al. Genetic influences on F cells and other hematologic variables: a twin heritability study. Blood 2000; a 95 (01) 342-346
- 8 Garner C, Tatu T, Game L. et al. A candidate gene study of F cell levels in sibling pairs using a joint linkage and association analysis. GeneScreen 2000; b 1: 9-14
- 9 Steinberg MH, Sebastiani P. Genetic modifiers of sickle cell disease. Am J Hematol 2012; 87 (08) 795-803
- 10 Bae HT, Baldwin CT, Sebastiani P. et al. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans. Blood 2012; 120 (09) 1961-1962
- 11 Kar BC, Satapathy RK, Kulozik AE. et al. Sickle cell disease in Orissa State, India. Lancet 1986; 2 (8517): 1198-1201
- 12 Chies JA, Hutz MH. High frequency of the CCR5delta32 variant among individuals from an admixed Brazilian population with sickle cell anemia. Braz J Med Biol Res 2003; 36 (01) 71-75
- 13 Gil GP, Ananina G, Oliveira MB. et al. Polymorphism in the HMOX1 gene is associated with high levels of fetal hemoglobin in Brazilian patients with sickle cell anemia. Hemoglobin 2013; 37 (04) 315-324
- 14 Geard A, Pule GD, Chetcha Chemegni B. et al. Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon. Br J Haematol 2017; 178 (04) 629-639
- 15 Chirico EN, Pialoux V. Role of oxidative stress in the pathogenesis of sickle cell disease. IUBMB Life 2012; 64 (01) 72-80
- 16 Maines MD. Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB J 1988; 2 (10) 2557-2568
- 17 Belcher JD, Beckman JD, Balla G, Balla J, Vercellotti G. Heme degradation and vascular injury. Antioxid Redox Signal 2010; 12 (02) 233-248
- 18 Steinberg MH. Predicting clinical severity in sickle cell anaemia. Br J Haematol 2005; 129 (04) 465-481
- 19 Gilman JG, Huisman THJ. DNA sequence variation associated with elevated fetal G gamma globin production. Blood 1985; 66 (04) 783-787
- 20 Mashon RS, Dash PM, Khalkho J. et al. Higher fetal hemoglobin concentration in patients with sickle cell disease in eastern India reduces frequency of painful crisis. Eur J Haematol 2009; 83 (04) 383-384
- 21 Kulozik AE, Kar BC, Satapathy RK, Serjeant BE, Serjeant GR, Weatherall DJ. Fetal hemoglobin levels and β (s) globin haplotypes in an Indian populations with sickle cell disease. Blood 1987; 69 (06) 1742-1746
- 22 Ono K, Goto Y, Takagi S. et al. A promoter variant of the heme oxygenase-1 gene may reduce the incidence of ischemic heart disease in Japanese. Atherosclerosis 2004; 173 (02) 315-319
- 23 Roy P, Bhattacharya G, Mandal A. et al. Influence of BCL11A, HBS1L-MYB, HBBP1 single nucleotide polymorphisms and the HBG2 XmnI polymorphism On Hb F levels. Hemoglobin 2012; 36 (06) 592-599
- 24 Kerdpoo S, Limweeraprajak E, Tatu T. Effect of Swiss-type heterocellular HPFH from XmnI-Gγ and HBBP1 polymorphisms on HbF, HbE, MCV and MCH levels in Thai HbE carriers. Int J Hematol 2014; 99 (03) 338-344
- 25 Belisário AR, Martins ML, Brito AMS, Rodrigues CV, Silva CM, Viana MB. β-globin gene cluster haplotypes in a cohort of 221 children with sickle cell anemia or Sβ0-thalassemia and their association with clinical and hematological features. Acta Haematol 2010; 124 (03) 162-170
- 26 Bakr S, Khorshied M, Talha N. et al. Implication of HMOX1 and CCR5 genotypes on clinical phenotype of Egyptian patients with sickle cell anemia. Ann Hematol 2019; 98 (08) 1805-1812
- 27 Chinedu O. et al. Polymorphisms in the heme oxygenase-1 and bone morphogenetic protein receptor type 1b genes and estimated glomerular filtration rate in Brazilian sickle cell anemia patients. Hematol Transfus Cell Ther 2020; 16: 30035-30043
- 28 Jaseb K, Ramezani A, Far MAJ. et al. Association between beta globin haplotypes, HBBP1 and HMOX1 polymorphisms in relation to HbF among sickle cell anaemia patients: a study in Southwest Iran. Comp Clin Pathol 2017; 26: 1149-1155
- 29 Rueda B, Oliver J, Robledo G. et al. HO-1 promoter polymorphism associated with rheumatoid arthritis. Arthritis Rheum 2007; 56 (12) 3953-3958
- 30 Cao Y-A, Kusy S, Luong R, Wong RJ, Stevenson DK, Contag CH. Heme oxygenase-1 deletion affects stress erythropoiesis. PLoS One 2011; 6 (05) e20634
- 31 Bhagat S, Patra PK, Thakur AS. Fetal haemoglobin and β-globin gene cluster haplotypes among sickle cell patients in Chhattisgarh. J Clin Diagn Res 2013; 7 (02) 269-272
- 32 Keikhaei B, Galehdari H, Pedram M, Bashirpour S, Zandian K, Samadi B. Beta-globin gene cluster haplotypes in Iranian sickle cell patients: relation to some hematologic. Iran J Blood Cancer 2012; 4 (03) 105-110